Items where Author is "Esfahani, A."
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
(2022) Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. p. 10.
(2017) Effect of PUFAs Oral Administration on the Amount of Apoptotic Caspases Enzymes in Gastric Cancer Patients Undergoing Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry. pp. 93-101. ISSN 1871-5206